ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 96

$963K Total Retail Price of All Prescriptions

Rank: 10 out of 96

494 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

5% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 17,399 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 780 760 1 3
FUROSEMIDE 661 635 2 4
SIMVASTATIN 584 542 3 1
AMLODIPINE BESYLATE 504 476 4 2
WARFARIN SODIUM 498 498 5 6
OMEPRAZOLE 476 441 6 5
DONEPEZIL HCL 449 449 7 8
CITALOPRAM HBR 435 419 8 25
MIRTAZAPINE 420 420 9 14
NAMENDA 395 395 10 11
LISINOPRIL 386 386 11 10
METOPROLOL TARTRATE 365 363 12 7
POTASSIUM CHLORIDE 311 310 13 19
DIVALPROEX SODIUM 260 249 14 41
ATORVASTATIN CALCIUM 239 235 15 12
METOPROLOL SUCCINATE 232 232 16 9
TAMSULOSIN HCL 220 220 17 29
GABAPENTIN 209 208 18 20
ZOLPIDEM TARTRATE 199 198 19 18
DIGOXIN 195 195 20 34
ATENOLOL 193 188 21 30
METFORMIN HCL 170 146 22 13
DIOVAN 168 168 23 17
RISPERIDONE 164 153 24 31
POLYETHYLENE GLYCOL 3350 162 162 25 53
OXYCODONE-ACETAMINOPHEN 152 145 S2 26 26
CARBIDOPA-LEVODOPA 146 135 27 48
CARVEDILOL 145 132 28 22
PRAVASTATIN SODIUM 137 137 29 33
FAMOTIDINE 132 132 30 21
IPRATROPIUM-ALBUTEROL 131 130 31 57
FENTANYL 128 127 S2 32 50
SANTYL 121 121 33 71
LEVETIRACETAM 117 115 34 61
GLIMEPIRIDE 115 115 35 43
TRIAMCINOLONE ACETONIDE 113 107 36 125
HYDROCHLOROTHIAZIDE 112 112 37 16
OXYBUTYNIN CHLORIDE 110 100 38 145
QUETIAPINE FUMARATE 109 109 39 32
MELOXICAM 106 104 40 65
FINASTERIDE 105 105 41 85
LOSARTAN POTASSIUM 103 103 42 23
TRAZODONE HCL 99 95 43 38
SERTRALINE HCL 97 96 44 15
FLUTICASONE PROPIONATE 95 94 45 55
GLIPIZIDE 94 94 46 62
ESCITALOPRAM OXALATE 93 93 47 24
JANUVIA 92 89 48 49
OLANZAPINE 91 91 49 76
DILTIAZEM 24HR CD 89 89 50 83
EXELON 88 88 51 47
AMIODARONE HCL 88 87 51 103
PANTOPRAZOLE SODIUM 85 83 53 44
ADVAIR DISKUS 83 82 54 46
CLOPIDOGREL 79 79 55 27
OXYCODONE HCL 76 65 S2 56 95
ALLOPURINOL 76 74 56 82
SPIRONOLACTONE 72 57 58 70
NATEGLINIDE 69 69 59 230
LANTUS 68 67 60 68
OXYCONTIN 68 67 S2 60 118
TIMOLOL MALEATE 68 68 60 156
LATANOPROST 67 67 63 77
PLAVIX 66 66 64 42
RAMIPRIL 65 49 65 69
RANITIDINE HCL 65 64 65 75
LEVOFLOXACIN 63 63 67 59
ENALAPRIL MALEATE 63 63 67 28
BACLOFEN 63 43 67 108
PAROXETINE HCL 58 58 70 66
CEPHALEXIN 57 53 71 186
VENLAFAXINE HCL 57 57 71 252
NYSTATIN 56 56 73 86
ACETAMINOPHEN-CODEINE 56 56 S3 73 113
PREDNISONE 56 56 73 58
PRANDIN 55 55 76 147
KLOR-CON M20 55 55 76 91
LYRICA 55 44 76 73
OXCARBAZEPINE 55 44 76 154
TRAVATAN Z 54 54 80 79
SYNTHROID 50 48 81 99
CRESTOR 50 49 81 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.